The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acalabrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): Results of a phase 2, multicenter, open-label trial.
 
L Elizabeth Budde
Consulting or Advisory Role - BeiGene; Kite/Gilead; Novartis; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Merck; MustangBio
Patents, Royalties, Other Intellectual Property - CCR4 CAR T cells for treatment of patients with CCR4 positive cancer.; CD33CAR for treatment of patients with CD33+ acute myeloid leukemia.
Travel, Accommodations, Expenses - Kite/Gilead; Roche/Genentech
 
Morton Coleman
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Acerta Pharma/AstraZeneca; Arcus Biosciences; AstraZeneca; BeiGene; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Genfleet Therapeutics; GlaxoSmithKline; Hutchison MediPharma; Incyte; Ipsen; Lilly; MEI Pharma; Merck; Napo Pharmaceuticals; Novartis; Pfizer; Seagen
 
Don A. Stevens
No Relationships to Disclose
 
Shuo Ma
Consulting or Advisory Role - AbbVie; AstraZeneca; BeiGene; Genentech; Janssen; Pharmacyclics; TG Therapeutics; Verastem
Speakers' Bureau - AstraZeneca; BeiGene; Janssen; Pharmacyclics
Research Funding - AbbVie; AstraZeneca; BeiGene; Janssen; Juno Therapeutics; Loxo; Pharmacyclics; TG Therapeutics
 
Caterina Patti
No Relationships to Disclose
 
M. Yair Levy
Honoraria - AbbVie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Dova Pharmaceuticals; Epizyme; Gilead Sciences; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Morphosys; Novartis; Seagen; Takeda; TG Therapeutics
Consulting or Advisory Role - AbbVie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Dova Pharmaceuticals; Epizyme; Gilead Sciences; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Morphosys; Novartis; Seagen; Takeda; TG Therapeutics
 
Izidore S. Lossos
Honoraria - Janssen Biotech
Consulting or Advisory Role - Janssen Scientific Affairs; Seagen; Verastem
Research Funding - NCI
Patents, Royalties, Other Intellectual Property - Stanford- Royalties
 
Praveen Ramakrishnan Geethakumari
Consulting or Advisory Role - Kite, a Gilead Company; Pharmacyclics; Rafael Pharmaceuticals
 
Selay Lam
Honoraria - AbbVie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Roche; Sanofi; Seagen
Consulting or Advisory Role - AbbVie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Roche; Sanofi; Seagen
 
Roser Calvo
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Kara Higgins
Employment - AstraZeneca; PROMETRIKA
 
Paolo Strati
Consulting or Advisory Role - ADC Therapeutics; Genentech/Roche; TG Therapeutics
Research Funding - ALX Oncology; AstraZeneca